ID
19880
Description
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form is to be obtained in Baseline week 0 and every 4 weeks (week 4 to week 116).
Mots-clés
Versions (2)
- 30/01/2017 30/01/2017 -
- 31/01/2017 31/01/2017 -
Téléchargé le
30 janvier 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Vital signs study drug infusion CRFs Multiple Sclerosis Tysabri NCT00027300
Vital signs study drug infusion CRFs Multiple Sclerosis Tysabri NCT00027300
Description
Study drug infusion
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0008972
- UMLS CUI-3
- C1289919
Description
Infusion given
Type de données
boolean
Alias
- UMLS CUI [1]
- C1289919
Description
Reason
Type de données
text
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C0392360
Description
Date of infusion
Type de données
date
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C0011008
Description
Time infusion started
Type de données
time
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C0040223
- UMLS CUI [1,3]
- C0439659
Description
Time infusion stopped
Type de données
time
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C0040223
- UMLS CUI [1,3]
- C1522314
Description
Infusion volume prepared
Type de données
float
Unités de mesure
- mL
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C2700258
- UMLS CUI [1,3]
- C4082130
Description
Infusion volume infused
Type de données
float
Unités de mesure
- mL
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C2700258
- UMLS CUI [1,3]
- C1514756
Description
Infusion interrupted
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C1512900
Description
Reason
Type de données
text
Alias
- UMLS CUI [1,1]
- C1289919
- UMLS CUI [1,2]
- C0392360
Description
Vital signs within 1 hour post-infusion
Alias
- UMLS CUI-1
- C0518766
Description
Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C0011008
Description
Time
Type de données
time
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C0040223
Description
Vody temperature
Type de données
float
Unités de mesure
- °C
Alias
- UMLS CUI [1]
- C0005903
Description
Blood pressure
Type de données
text
Unités de mesure
- mmHg
Alias
- UMLS CUI [1]
- C0005823
Description
Pulse
Type de données
float
Unités de mesure
- beats/minute
Alias
- UMLS CUI [1]
- C0232117
Similar models
Vital signs study drug infusion CRFs Multiple Sclerosis Tysabri NCT00027300
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C1289919 (UMLS CUI-3)
C0392360 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0439659 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])
C2700258 (UMLS CUI [1,2])
C4082130 (UMLS CUI [1,3])
C2700258 (UMLS CUI [1,2])
C1514756 (UMLS CUI [1,3])
C1512900 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])